Non-Invasive Brain Stimulation to Improve Language in Down Syndrome.
A legfontosabb adatok
- Ki végzi
- Floriana Costanzo
- Hol
- Olaszország1 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 36 fő, tervezett
- Kezdés
- 2025. jan. 27.
- Tervezett befejezés
- 2026. szept. 30.
- A vizsgálat típusa
- Beavatkozással járó, 3 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
- A vizsgált kezelések
- Active Group (Active Anodal tDCS to the left IFG or Cathodal tDCS to the left IFG)
- Sham Group
- A regiszteradat frissítve
- 2026. július 24.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for Italian-speaking adolescents and young adults with Down syndrome who have language difficulties. It tests mild brain stimulation (tDCS) combined with speech and language training.
- Életkor
- 12 to 21 years
- Nem
- All sexes
- A betegség stádiuma
- Down syndrome (free trisomy 21) shown by a chromosome test (karyotyping). Mental age of 4 years or more on the Leiter-3 test. Naming test score (BVL_4-12) below 2 SD, but not under 10 points. Speech must be at least partly understood by close relatives (ICS score cut-off 3.5).
- Korábbi kezelés
- People cannot join if they currently have speech therapy, or medicines for thinking or behaviour.
- Biomarker vagy leletérték
- Free trisomy 21 confirmed by karyotyping.
A részvétel fő kizáró okai
- Hearing loss or serious sight problems
- Epilepsy, or epilepsy in the family
- Major mental health disorders
- Repeats fewer than 7 of 10 words in a word-copying test
- Current speech therapy or medicines for thinking or behaviour
A regiszter feltételei, szó szerint
Mind a 11 feltétel megnézéseKevesebb
Ki vehet részt
- Italian speakers participants of both genders with the presence of a free trisomy 21 documented by karyotyping
- Adolescents and young adults from 12 to 21 years old
- Mental age ≥ 4 years (as assessed by Leiter-3 at baseline)
- Scores < 2 SD at the denomination subtest of BVL_4-12
- Be comprehensible to closest relatives, at least in part, exhibiting consistent speech sounds mesured by Intelligibility in Context Scale (ICS): Italian (McLeod, Harrison, \& McCormack, 2012) with a cut-off of 3.5
- Informed consent/absent from each patient and Informed consent from their caregivers
Ki nem vehet részt
- Undergoing concomitant speech therapy or psychopharmacological therapy for cognitive or behavioral improvement
- The presence of epilepsy, familiarity with epilepsy and major psychopathological disorders
- The presence of any neurosensory deficits, such as hypoacusis or serious visual impairments
- Scores < 10 points at the denomination subtest of BVL_4-12
- Ability to verbally imitate less that 7 of 10 words during an imitation screening task
Nézd meg, megfelelhetsz-e
Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.
- 12 és 21 év között vagy?
Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
Down syndrome (DS) is associated with cognitive deficits, caused by alterations in neuroplasticity and synaptic transmission. Non-invasive brain stimulation techniques, such as transcranial direct current stimulation (tDCS), can modulate the brain's plasticity mechanisms and neurotransmitter balance.
A teljes eredeti leírásKevesebb
Anodal tDCS increases cortical excitability by depolarizing neurons, while cathodal tDCS decreases it through hyperpolarization. When combined with cognitive training, tDCS may produce faster and longer-lasting therapeutic effects. Although most of the neurorehabilitation studies have applied anodal excitatory stimulation, recent evidence suggests the potential cathodal inhibitory stimulation in neurodevelopmental disorders with alteration of synaptic transmission, as people with DS. Potentially both anodal and cathodal stimulation protocols could lead to positive clinical effects in DS.
This proof-of-concept study is a double-blind, placebo-controlled, clinical trial aiming to evaluate the efficacy of two active tDCS protocols (anodal and cathodal) targeting the left inferior frontal gyrus (IFG) versus sham stimulation tDCS, combined with speech and language training, to improve language skills in adolescents and young adults with DS. The study also aims to identify the most effective parameters of tDCS treatment, for customization in adolescents and young adults with DS. Thirty-six participants, aged 12 to 21 years, will be randomly assigned to three groups receiving anodal, cathodal, or sham tDCS. Each participant will undergo 10 sessions of tDCS at 1 mA for 20 minutes, alongside speech and language training five times for two weeks.
Neuropsychological, behavioral, biomarker (including brain-derived neurotrophic factor and neurofilament light chain), and electroencephalogram assessments will be performed at baseline, post-treatment, and three months after treatment completion. The study hypothesizes that tDCS will enhance language abilities, particularly expressive vocabulary, and modulate biomarkers of brain plasticity in DS participants. The study also hypothesizes that tDCS will enhance other cognitive and behavioral functions. Since tDCS effects may last, the study will check for improvements at the three-month. If effective, this combined approach of tDCS and language training could pave the way for new rehabilitation strategies for DS.
A vizsgálat 3 csoportja
- Active Anodal tDCS to the left IFGMár használt kezelés, összehasonlításként
Anodal- tDCS will be delivered by a battery driven, constant current stimulator through a pair of saline-soaked sponge electrodes kept firm by elastic bands. The device employed will be the BrainStim+ (REF: EMS BSTIM+), a lightweight, battery-operated constant current stimulator.The active electrode will be placed on the left IFG cortex (between F5 and F7 of the extended International 10-20 system for EEG electrode placement) cortex and the reference electrode placed above the contralateral shoulder, as previously applied in DS.Stimulation intensity will be set at 1 mA; the duration of stimulation will be 20 min and will be held five consecutive daily session per week for two weeks for a total of 10 sessions. During the tDCS sessions participant will sit in a comfortable chair and a language training will be administered for 20 minutes.
Kezelés: Active Group (Active Anodal tDCS to the left IFG or Cathodal tDCS to the left IFG)
- Active Cathodal tDCS to the left IFGMár használt kezelés, összehasonlításként
Cathodal- tDCS the cathode will be placed on the left IFG (between F5 and F7 of the extended International 10-20 system for EEG electrode placement) cortex, while the anode will be placed above the right shoulder. The device employed will be the BrainStim+ (REF: EMS BSTIM+), a lightweight, battery-operated constant current stimulator. Stimulation intensity will be set at 1 mA; the duration of stimulation will be 20 min and will be held five consecutive daily session per week for two weeks for a total of 10 sessions. During the tDCS sessions participant will sit in a comfortable chair and a language training will be administered for 20 minutes.
Kezelés: Active Group (Active Anodal tDCS to the left IFG or Cathodal tDCS to the left IFG)
- Sham tDCS to the left IFGSzínlelt kezelés, összehasonlításként
In the sham condition, participants will undergone electrode placements identical to those used in either the anodal or cathodal tDCS configurations, with equal allocation to each montage. The BrainStim+ device (REF: EMS BSTIM+), a lightweight, battery-operated constant current stimulator, will be used. However, the current will be applied only briefly for 30 seconds before being ramped down in a manner imperceptible to the participant, thereby simulating the initial sensation of stimulation without delivering an active dose. Sham sessions will follow the same schedule as the active conditions-20 minutes per session, five consecutive daily sessions per week over two weeks (total of 10 sessions). During each session, participants will be seated comfortably and engage in concurrent language training.
Kezelés: Sham Group
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Brain-directed Treatment to Improve Language in Adolescents and Young Adults With Down Syndrome: the Efficacy of Transcranial Direct Current Stimulation Coupled With Linguistic Training.
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- Illeszkedési kérdések
- Forrás: NCT07044804: ki vehet részt
- A regiszteradat frissítve
- 2026. július 24.